Letter: Drugs for rare diseases.
D002614:Chelating Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004345:Drug Industry; D004739:England; D005029:Ethylenediamines / Q000627:therapeutic use*; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans
D002614:Chelating Agents; D005029:Ethylenediamines